ITMI20051231A1 - PHARMACEUTICAL FORMULATIONS CONTAINING COLOSTRUM AND FOLINATED CALCIUM FOR THE TREATMENT OF ORAL CABLE AFFECTIONS - Google Patents

PHARMACEUTICAL FORMULATIONS CONTAINING COLOSTRUM AND FOLINATED CALCIUM FOR THE TREATMENT OF ORAL CABLE AFFECTIONS

Info

Publication number
ITMI20051231A1
ITMI20051231A1 IT001231A ITMI20051231A ITMI20051231A1 IT MI20051231 A1 ITMI20051231 A1 IT MI20051231A1 IT 001231 A IT001231 A IT 001231A IT MI20051231 A ITMI20051231 A IT MI20051231A IT MI20051231 A1 ITMI20051231 A1 IT MI20051231A1
Authority
IT
Italy
Prior art keywords
folinated
affections
oral
calcium
cable
Prior art date
Application number
IT001231A
Other languages
Italian (it)
Inventor
Rosa Gobbi
Original Assignee
Pharmaproducts Uk Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmaproducts Uk Ltd filed Critical Pharmaproducts Uk Ltd
Priority to IT001231A priority Critical patent/ITMI20051231A1/en
Priority to EP06779775A priority patent/EP1906979A1/en
Priority to PCT/IB2006/001746 priority patent/WO2007000648A1/en
Publication of ITMI20051231A1 publication Critical patent/ITMI20051231A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
    • A61K8/981—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of mammals or bird
    • A61K8/986—Milk; Derivatives thereof, e.g. butter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Developmental Biology & Embryology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IT001231A 2005-06-29 2005-06-29 PHARMACEUTICAL FORMULATIONS CONTAINING COLOSTRUM AND FOLINATED CALCIUM FOR THE TREATMENT OF ORAL CABLE AFFECTIONS ITMI20051231A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
IT001231A ITMI20051231A1 (en) 2005-06-29 2005-06-29 PHARMACEUTICAL FORMULATIONS CONTAINING COLOSTRUM AND FOLINATED CALCIUM FOR THE TREATMENT OF ORAL CABLE AFFECTIONS
EP06779775A EP1906979A1 (en) 2005-06-29 2006-06-27 Pharmaceutical formulations containing colostrum and calcium folinate for te treatment of disorders of the oral cavity
PCT/IB2006/001746 WO2007000648A1 (en) 2005-06-29 2006-06-27 Pharmaceutical formulations containing colostrum and calcium folinate for te treatment of disorders of the oral cavity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT001231A ITMI20051231A1 (en) 2005-06-29 2005-06-29 PHARMACEUTICAL FORMULATIONS CONTAINING COLOSTRUM AND FOLINATED CALCIUM FOR THE TREATMENT OF ORAL CABLE AFFECTIONS

Publications (1)

Publication Number Publication Date
ITMI20051231A1 true ITMI20051231A1 (en) 2006-12-30

Family

ID=37196323

Family Applications (1)

Application Number Title Priority Date Filing Date
IT001231A ITMI20051231A1 (en) 2005-06-29 2005-06-29 PHARMACEUTICAL FORMULATIONS CONTAINING COLOSTRUM AND FOLINATED CALCIUM FOR THE TREATMENT OF ORAL CABLE AFFECTIONS

Country Status (3)

Country Link
EP (1) EP1906979A1 (en)
IT (1) ITMI20051231A1 (en)
WO (1) WO2007000648A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20080174A1 (en) * 2008-02-05 2009-08-06 You Biomedical Research Srl TOPIC COMPOSITIONS BASED ON COLOSTRUM, FOLATE AND ROSE HONEY FOR THE TREATMENT OF ORAL CAVITY AFFECTIONS
ITMI20112446A1 (en) * 2011-12-30 2013-07-01 Bionest Ltd COMPOSITION FOR THE THERAPY OF INJURIES OF ORAL MUCOSA
WO2013098333A1 (en) 2011-12-30 2013-07-04 Bionest Ltd. Combination of growth factors, cytokines, antibacterial/antiviral factors, stem cell stimulating factors, complement proteins c3a/c4a, immunoglobulins and chemotactic factors
EP2797610A1 (en) * 2011-12-30 2014-11-05 BIONEST Ltd. Combination of growth factors, cytokines, antibacterial/antiviral factors, stem cell stimulating factors, complement proteins c3a/c4a, and chemotactic factors
US10272083B2 (en) 2014-01-21 2019-04-30 Acerta Pharma B.V. Methods of treating chronic lymphocytic leukemia and small lymphocytic leukemia using a BTK inhibitor
MX2020014163A (en) 2015-07-02 2022-09-29 Acerta Pharma Bv Solid forms and formulations of (s)-4-(8-amino-3-(1 -(but-2-ynoyl)pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-n-(py ridin-2-yl)benzamide.
US20190076497A1 (en) * 2017-09-11 2019-03-14 Kenneth Davin Fine Oral and intestinal health products
US10933097B1 (en) 2020-03-05 2021-03-02 King Saud University Method of treating a bacterial infection using colostrum

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4500711A (en) * 1977-03-21 1985-02-19 Burroughs Wellcome Co. Synthesis of leucovorin
FR2627386A1 (en) * 1988-02-22 1989-08-25 Serge Liotet Compsns. for topical application to eyes - contg. colostrum lactoserum and vitamin=a
ES2102813T3 (en) * 1993-01-26 1997-08-01 Horse Vitality Ltd PHARMACEUTICAL AND DERMOCOSMETIC COMPOSITIONS CONTAINING EQUINE COLOSTRY.
IT1291340B1 (en) * 1997-05-09 1999-01-07 Vander Way Limited PHARMACEUTICAL FORMULATIONS CONTAINING COLOSTRUM AND USE OF COLOSTRUM FOR THE TREATMENT OF ORAL CAVITY DISEASES

Also Published As

Publication number Publication date
WO2007000648A1 (en) 2007-01-04
EP1906979A1 (en) 2008-04-09

Similar Documents

Publication Publication Date Title
CY2013022I1 (en) COMPOSITIONS FOR THE THERAPEUTIC TREATMENT OF GASTROINTESTINAL DISORDERS
GB0522311D0 (en) Pharmaceutical compositions for the treatment of pain
ITMI20020756A0 (en) TOPICAL PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF DERMATITIS
CY2018006I1 (en) THERAPEUTIC FORMULATION OF CLADRIVINE FOR THE THERAPEUTIC TREATMENT OF PLAQUE STICHERONE
BRPI0917444A2 (en) gastric retention pharmaceutical compositions for the treatment and prevention of snc diseases
HUE041944T2 (en) Low dose imiquimod formulations and short dosing method for the treatment of actinic keratosis
PT1605956E (en) ADMINISTRATION OF CAPSAICINOIDS FOR THE TREATMENT OF OSTEOARTRITE
IS8398A (en) Drug formulations for the treatment of tumors
CY2014026I2 (en) COMPOSITIONS AND USES FOR THE TREATMENT OF PLAQUE SHELDERING
IL179674A0 (en) Chemical compounds and pharmaceutical compositions containing them for the treatment of inflammatory disorders
HUS1500058I1 (en) Benzoxazine-containing drug combination for the treatment of respiratory diseases
IL189622A (en) Pharmaceutical compositions for the treatment of inner ear disorders
EP2046315A4 (en) THERAPEUTIC AGENTS FOR TREATMENT MALIGNER LYMPHOME
IS7691A (en) Drug formulations for the treatment of tumors
IL202111A0 (en) Formulations for the oral administration of therapeutic agents and related methods
EP1804787A4 (en) FLAVONOID COMPOSITION FOR THE TREATMENT OF ORAL DISEASES
ITMI20051231A1 (en) PHARMACEUTICAL FORMULATIONS CONTAINING COLOSTRUM AND FOLINATED CALCIUM FOR THE TREATMENT OF ORAL CABLE AFFECTIONS
IL186022A0 (en) Dermatological compositions and salts for the treatment of dermatological diseases
IL183893A0 (en) Pharmaceutical compositions for the treatment of cellulite
IT1390968B1 (en) GLYCOLIPIDAL FRACTION OF CIANOBATTERIO FOR THE TREATMENT OF ORAL CABLE AFFECTIONS
EE200800065A (en) Active ingredient containing P rasolop rimidinone compound for the maintenance and treatment of "pre-enlargement"
SI2344166T1 (en) Pharmaceutical composition for the treatment of gastrointestinal irritation disorders
HU0500145D0 (en) Composition for the treatment of oral diseases
ITMI20061741A1 (en) PHARMACEUTICAL COMPOSITIONS FOR ORAL ADMINISTRATION OF PROTEIN SUBSTANCES
ITMI20040989A1 (en) USE OF SULGLICOTIDE FOR THE TREATMENT OF MUCOSITES